ROS levels assessed in peripheral and central sensory neurons following paclitaxel.
Increased ROS levels seen in non-peptidergic neurons prior to paclitaxel-induced pain.
Elevated ROS levels in spinal neurons, but not microglia/astrocytes, after paclitaxel.
Assayed activity of main antioxidant enzymes during paclitaxel-evoked pain timecourse.
Inadequate antioxidant response suggests elevated ROS sustains paclitaxel-evoked pain.